TAF for HIV-HBV With Renal Dysfunction
NCT03115736
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
HIV and Hepatitis B Coinfection
Interventions
DRUG:
Tenofovir Alafenamide
Sponsor
Insel Gruppe AG, University Hospital Bern